Gradientech installs QuickMIC system at Uppsala University Hospital for beta testing

Gradientech AB has announced the first external installation of its QuickMIC system, designed for rapid antibiotic susceptibility testing (AST). The system is currently deployed at Uppsala University Hospital in Sweden for a beta test study.

The installation involves QuickMIC instrument modules, which received approval for research use last year. The study will analyze 30 clinical samples from sepsis patients infected with gram-negative bacteria. This deployment marks a significant step in verifying the system's performance in a real-world clinical setting.

"We are very excited about the ongoing collaboration with Uppsala University Hospital and foresee a long-term partnership that adds value to both parties," said Sara Thorslund, CEO of Gradientech. "Placing our QuickMIC system externally for the first time was an important milestone for Gradientech. The input received so far from the clinical microbiology staff involved in beta testing has been very positive."

Uppsala University Hospital is one of Sweden's largest hospitals and a key partner for Gradientech. The hospital will continue to be involved in future studies aimed at obtaining regulatory CE-IVD approval for the QuickMIC system, a crucial step for its broader clinical adoption and contribution to combating antibiotic resistance.